Yuhan Corporation exercises warrants and oversubscribes in ImmuneOncia's rights offering, acquiring 2.74M new shares at KRW 4,860, ownership drops to 56.62% from 65.75%
Yuhan Corporation, the largest shareholder of ImmuneOncia, exercised its existing warrants (2.396M shares) and acquired an additional 345,503 shares through oversubscription in the company's rights offering, totaling 2,741,669 new shares at KRW 4,860 per share.
As a result, Yuhan's common share holdings increased from 48,891,724 to 51,633,393 shares, but its ownership percentage decreased from 65.75% to 56.62% due to the increase in total outstanding shares from the offering.
Yuhan's active participation signals confidence in the company's fundraising, but the discounted issuance price (KRW 4,860 vs. market price KRW 6,200) dilutes the value for non-participating shareholders.
[AI Comprehensive Analysis]This disclosure is a routine report of a major shareholder's exercise of rights and share acquisition, unlikely to significantly impact short-term stock price. However, the discounted new share issuance may pose a dilution risk for minority shareholders.
KOSDAQ Filing Information
Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders